Cognitive decline and dementia under the spotlight: a growing issue in Italy and Worldwide
On September 18, 2024, during Alzheimer’s Awareness Month, Neopharmed Gentili held a press conference titled “COGNITIVE DECLINE AND DEMENTIA: WHAT DO WE KNOW, WHAT ARE WE DOING, AND WHAT IS THE IMPACT ON SOCIETY AND THE NATIONAL HEALTH SERVICE?” which brought together clinical experts in cognitive decline, health economics, and patient associations.
This initiative stems from Neopharmed Gentili’s commitment to improving the quality of life for people, especially during aging, by promoting awareness of the importance of prevention and early diagnosis, while challenging the prejudices that distance patients from care pathways.
The event was an opportunity to raise awareness about the impact of cognitive decline and dementia on patients, society, and the healthcare system, and the tools available for managing these conditions.
According to the Dementia Observatory of the Italian National Institute of Health (ISS), mild cognitive decline and dementia affect around 2 million Italians, and nearly 4 million individuals are directly or indirectly involved in patient care.
Read the in-depth report: Mild Cognitive Decline and Dementia – A Growing Problem, download it here!
Intervening in the preclinical stages of dementia is crucial in preventing disease progression. Studies have shown that addressing all modifiable risk factors between the ages of 40 and 60 could reduce the development of mild cognitive decline into dementia by 40%. This includes addressing smoking, alcohol consumption, physical inactivity, diabetes, hypertension, dyslipidemia, as well as social engagement.
Read the guide “Ten Healthy Habits for Cognitive Health”, download it here!
According to a survey conducted by the research institute ‘EMG Different,’ 9 out of 10 Italians are worried that either they or a loved one may suffer from mild cognitive decline or dementia in the future, especially fearing the loss of autonomy, isolation, and the emotional and financial burden on the family.
The symptoms of the condition are numerous and complex, with memory impairment being the most prominent signal, often downplayed due to the stigma that relegates it to a normal aspect of aging. Other warning signs include the onset of depression, changes in personality, and difficulty in maintaining conversations.
Dementia is not a condition to be passively accepted. A shared commitment is needed, which is why new guidelines have been published on “Diagnosis and Treatment of Dementia and Mild Cognitive Impairment,” covering diagnosis, treatment, care, and support for patients, enabling them to maintain a good quality of life.
Read the “Cognitive Decline and Dementia” report by EMG Different, download it here!
